Case report: Giant pituitary neuroendocrine tumor presented along with acute visual loss due to pituitary apoplexy after receiving COVID-19 vaccination

OBJECTIVE: A case of giant pituitary neuroendocrine tumor presented along with acute visual loss due to pituitary apoplexy after receiving a COVID-19 vaccination is reported. CASE PRESENTATION: A 45-year-old man was referred for a giant pituitary tumor with bitemporal hemianopsia. A surgical procedu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Haku, Nishimura, Fumihiko, Nakase, Kenta, Yokoyama, Shohei, Nakagawa, Ichiro, Yamada, Shuichi, Tamura, Kentaro, Matsuda, Ryosuke, Takeshima, Yasuhiro, Kotsugi, Masashi, Park, Young-Soo, Nakase, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413133/
https://www.ncbi.nlm.nih.gov/pubmed/37576925
http://dx.doi.org/10.3389/fsurg.2023.1220098
Descripción
Sumario:OBJECTIVE: A case of giant pituitary neuroendocrine tumor presented along with acute visual loss due to pituitary apoplexy after receiving a COVID-19 vaccination is reported. CASE PRESENTATION: A 45-year-old man was referred for a giant pituitary tumor with bitemporal hemianopsia. A surgical procedure was planned and then delayed due to the COVID-19 outbreak in Japan, with a Pfizer/BioNTech vaccine administered while awaiting surgery. Three days after the second COVID-19 vaccination the patient noted a progressively worsening headache that caused pituitary apoplexy and then a decrease in vision. Emergency surgery was thus performed. CONCLUSION: Pituitary apoplexy is a rare and life-threatening complication that may occur after undergoing a COVID-19 vaccination.

Ejemplares similares